38 reports

  • DERMATOLOGY PRODUCTS AND R&D PIPELINE - VALEANT PHARMACEUTICALS
  • DERMATOLOGY PRODUCTS AND R&D PIPELINE - PIERRE FABRE
  • Acne Treatment
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • II. ACNE VULGARIS PIPELINE BY MOLECULE TYPE
  • Approved Benzoyl peroxide Products

PARATEK PHARMACEUTICALS, INC.

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • II. ACNE VULGARIS PIPELINE BY MOLECULE TYPE
  • Approved Benzoyl peroxide Products

PARATEK PHARMACEUTICALS, INC.

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • GLOBAL SALES OF DERMATOLOGICALS 2016
  • PASSPORT 27

Across its three divisions, including Pharmaceuticals, Consumer Health, and Crop Science and Animal Health together, the company spent close to USD## billion on R& D in 2016, which marked a ##% increase from the previous year and representing a ##% to ##% split between

  • Acne Treatment
  • Bayer AG
  • Herbalife Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Market size and forecast
  • Market segmentation by route of administration

Galderma, Valeant Pharmaceuticals, and Aqua Pharmaceuticals are the major players in this market in 2015.

  • Acne Treatment
  • Dermatological Condition
  • Allergan plc
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.
  • Mankind Pharmaceuticals - Acne Products
  • Sun Pharmaceuticals - Acne Products
  • Acne Treatment
  • India
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • Key Facts
  • PROSPECTS

Key Facts Strategic Direction Darou Pakhsh Pharmaceutical MFG is part of a holding company which dominates pharmaceutical sales in Iran.

  • Acne Treatment
  • OTC
  • Pharmaceutical
  • Iran
  • Demand

Valeant Pharmaceutical International, Inc. ##. ##. ##.

  • Acne Treatment
  • OTC
  • World
  • Market Size
  • DERMATOLOGICALS IN JAPAN - CATEGORY ANALYSIS
  • Taisho, Rohto and Kobayashi Launching New Products

Distribution: The Pharmaceuticals and Medical Devices Law also regulates OTC distribution.

  • Acne Treatment
  • Japan
  • Demand
  • Daiichi Sankyo Company
  • Taisho Pharmaceutical Co., Ltd.
  • OTHER COMPANIES CONTINUED
  • Industry Performance

The company, privately held for ## years, was acquired by Rohto Pharmaceutical Co.

  • Acne Treatment
  • Dermatological Condition
  • OTC
  • United States
  • Demand

Adapalene / Benzoyl Peroxide Sales Forecast ($mn) by Country, 2016 – 2021 Fore Pharma has released its new research, Adapalene / Benzoyl Peroxide Sales, Price Analysis, & Sales Forecast – 2017.

  • Acne Treatment
  • OTC
  • World
  • Demand

Benzoyl Peroxide / Erythromycin Sales Forecast ($mn) by Country, 2016 – 2021 Fore Pharma has released its new research, Benzoyl Peroxide / Erythromycin Sales, Price Analysis, & Sales Forecast – 2017.

  • Acne Treatment
  • Anti-Infective
  • OTC
  • World
  • Demand

Benzoyl Peroxide / Clindamycin Sales Forecast ($mn) by Country, 2016 – 2021 Fore Pharma has released its new research, Benzoyl Peroxide / Clindamycin Sales, Price Analysis, & Sales Forecast – 2017.

  • Acne Treatment
  • Anti-Infective
  • OTC
  • World
  • Demand

Benzoyl Peroxide Sales Forecast ($mn) by Country, 2016 – 2021 Fore Pharma has released its new research, Benzoyl Peroxide Sales, Price Analysis, & Sales Forecast – 2017.

  • Acne Treatment
  • OTC
  • World
  • Demand

Miconazole Sales Forecast ($mn) by Country, 2016 – 2021 Fore Pharma has released its new research, Miconazole Sales, Price Analysis, & Sales Forecast – 2017.

  • Acne Treatment
  • Anti-Infective
  • Therapy
  • World
  • Demand

The Sanitary Code (Decree ##) regulates the sale of OTC and prescription pharmaceuticals in Chile.

  • Acne Treatment
  • OTC
  • Chile
  • Demand
  • PURDUE PHARMA (67.2%)
  • COMBINED HANDWASHES/PERIOPERATIVE SKIN PREPARATIONS
  • Acne Treatment
  • United States
  • Covidien plc
  • Purdue Pharma L.P.
  • STERIS Corporation

Lastly, in March 2017, Meditonsin Tropfen by Sanova Pharma GesmbH was also switched from Rx to OTC.

  • Acne Treatment
  • OTC
  • Austria
  • Demand
  • Dynamic Brands Are Still Too Modest To Have A Real Impact on Sales

According to pharma. be, the Belgian pharmaceutical industry association, it began to significantly reduce the number of APPENDIX OTC Registration and Classification Passport ## pending cases in 2007 and 2008, although the system still needed to be evaluated via dialogue between th

  • Acne Treatment
  • OTC
  • Belgium
  • Demand

In addition, scepticism about the products of pharmaceutical multinationals has grown as a result of developments such as the scandal surrounding the drug, Mediator, encouraging the French to tend towards self-medication, with herbal-based OTC whenever possible.

  • Acne Treatment
  • OTC
  • France
  • Demand

Acne Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Japan Acne Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acne pipeline products, Acne epidemiology, Acne market valuations and forecast, Acne products sales and comp

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Japan
  • Market Shares

Acne Market Forecast ($), Germany, 2015 – 2020 The latest research from Fore Pharma, Germany Acne Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acne pipeline products, Acne epidemiology, Acne market valuations and forecast, Acne products sales and

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Germany
  • Market Shares

Acne Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, UK Acne Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acne pipeline products, Acne epidemiology, Acne market valuations and forecast, Acne products sales and competitiv

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • United Kingdom
  • Market Shares

Acne Market Forecast ($), Italy, 2015 – 2020 The latest research from Fore Pharma, Italy Acne Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acne pipeline products, Acne epidemiology, Acne market valuations and forecast, Acne products sales and comp

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Italy
  • Market Shares

Acne Market Forecast ($), France, 2015 – 2020 The latest research from Fore Pharma, France Acne Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acne pipeline products, Acne epidemiology, Acne market valuations and forecast, Acne products sales and co

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • France
  • Market Shares

A research paper published in May 2016 in the Journal of Pharmaceutical and Biomedical Analysis found that ##% of the ## " natural" weight loss supplements tested contained undisclosed active pharmaceutical ingredients.

  • Acne Treatment
  • Allergy Drug
  • OTC
  • United States
  • Demand

Acne Market Forecast ($), Spain, 2015 – 2020 The latest research from Fore Pharma, Spain Acne Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acne pipeline products, Acne epidemiology, Acne market valuations and forecast, Acne products sales and comp

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Spain
  • Market Shares

Acne Market Forecast ($), US, 2015 – 2020 The latest research from Fore Pharma, US Acne Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acne pipeline products, Acne epidemiology, Acne market valuations and forecast, Acne products sales and competitiv

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Market Shares

pharmaceuticals manufacturer Himpharm AO plans to double its profits.

  • Acne Treatment
  • Gastrointestinal Drug
  • Vitamin
  • Kazakhstan
  • Demand
  • Untitled
  • The US Acne Treatment Market by Value; 2014-2016 (US$ Billion)

Figure ##: Foamix Pharmaceuticals Ltd.

  • Acne Treatment
  • Dermatology
  • World
  • Market Size
  • Foamix Ltd.